Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$1.04B |
| 2 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$896M |
| 3 |
BHP
BHP
|
+$620M |
| 4 |
Amazon
AMZN
|
+$608M |
| 5 |
NVIDIA
NVDA
|
+$555M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$813M |
| 2 |
Walt Disney
DIS
|
+$667M |
| 3 |
Intel
INTC
|
+$658M |
| 4 |
UnitedHealth
UNH
|
+$649M |
| 5 |
Cisco
CSCO
|
+$646M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.43% |
| 2 | Healthcare | 10.84% |
| 3 | Financials | 9.96% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Communication Services | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Occidental Petroleum
OXY
$55.9B
| $47.8M | 0.03% |
843,251
+153,740
| +22% | +$6.8M |
|
227
Vericel Corp
VCEL
$2.31B
| $46.8M | 0.03% |
1,224,111
-12,564
| -1% | -$453K |
|
228
Rockwell Automation
ROK
$49B
| $45.9M | 0.03% |
163,802
+8,852
| +6% | +$2.54M |
|
229
CONMED
CNMD
$1.47B
| $45.2M | 0.03% |
304,525
-6,482
| -2% | -$905K |
|
230
iShares Core US Aggregate Bond ETF
AGG
$138B
| $45.1M | 0.03% |
421,527
+29,467
| +8% | +$3.24M |
|
|
BHVN
231
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $43.7M | 0.03% |
368,257
-4,281
| -1% | -$534K |
|
232
WIX.com
WIX
$2.52B
| $43.5M | 0.03% |
416,470
+46,432
| +13% | +$5.07M |
|
|
JHG
233
DELISTED
Janus Henderson
JHG
| $43.4M | 0.03% |
1,238,817
+11,424
| +0.9% | +$412K |
|
|
NUVA
234
DELISTED
NuVasive, Inc.
NUVA
| $42.5M | 0.03% |
750,274
-5,371
| -0.7% | -$285K |
|
235
Nice
NICE
$5.97B
| $40.3M | 0.02% |
183,836
+33,504
| +22% | +$8.12M |
|
236
Bilibili
BILI
$7.84B
| $38.6M | 0.02% |
1,508,421
-25,790
| -2% | -$830K |
|
237
Integra LifeSciences
IART
$1.34B
| $38.3M | 0.02% |
595,440
-6,611
| -1% | -$435K |
|
|
DVAX
238
DELISTED
Dynavax Technologies
DVAX
| $38.1M | 0.02% |
3,511,165
-94,614
| -3% | -$1.15M |
|
|
ENV
239
DELISTED
ENVESTNET, INC.
ENV
| $38M | 0.02% |
+510,150
| New | +$37.4M |
|
240
Plexus
PLXS
$7.23B
| $37.6M | 0.02% |
460,028
-2,581
| -0.6% | -$215K |
|
241
Halozyme
HALO
$12.2B
| $37.5M | 0.02% |
941,514
-1,216
| -0.1% | -$43.3K |
|
242
Nucor
NUE
$62.1B
| $36.9M | 0.02% |
248,542
-7,232
| -3% | -$887K |
|
243
Prestige Consumer Healthcare
PBH
$2.6B
| $36.6M | 0.02% |
691,918
| – | – |
|
|
MZTI
244
The Marzetti Company
MZTI
$3.11B
| $36.4M | 0.02% |
243,939
+3,112
| +1% | +$497K |
|
245
Honeywell
HON
$78B
| $36.2M | 0.02% |
197,325
-715
| -0.4% | -$132K |
|
246
Delek US
DK
$3.58B
| $34.9M | 0.02% |
1,644,530
+241,730
| +17% | +$4.39M |
|
247
Kulicke & Soffa
KLIC
$4.78B
| $34.7M | 0.02% |
618,783
+46,047
| +8% | +$2.54M |
|
248
EOG Resources
EOG
$70.7B
| $33.4M | 0.02% |
279,999
+5,304
| +2% | +$591K |
|
249
Alcon
ALC
$35B
| $33M | 0.02% |
415,520
-21,191
| -5% | -$1.64M |
|
|
AAWW
250
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $32.5M | 0.02% |
376,787
+5,783
| +2% | +$475K |
|
Similar funds
Ken Fisher's Q1 2022 Portfolio in Review
As of Q1 2022, Ken Fisher held 1,181 positions worth $169B, down 5.1% from $179B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher deployed $5.41B of net new capital in Q1 2022, opening 114 new positions and adding to 450 existing holdings. Its largest new stake was Shell: 19,596,216 shares worth $1.08B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $667M trimmed.
- Ken Fisher's largest Q1 2022 buy was Shell: 19,596,216 shares worth $1.08B.
- Ken Fisher added most to State Street SPDR Portfolio Long Term Treasury ETF in Q1 2022, an estimated $896M increase.
- Ken Fisher's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $667M.
- Ken Fisher fully exited Royal Dutch Shell PLC ADS Class A in Q1 2022, selling an estimated $813M.
- Ken Fisher's ten largest holdings make up 31% of its $169B portfolio in Q1 2022.
- Ken Fisher opened 114 new positions and closed 95 in Q1 2022.
- Ken Fisher's portfolio value fell 5.1% quarter-over-quarter to $169B.
Based on Fisher Asset Management's 13F filing for Q1 2022, filed 5 May 2022.